.STUDY FEATURE.06 August 2024.
A big randomized regulated trial with cisgender females highlights the difficulties of obedience to a daily dental preexposure prevention regiment and displays that twice-yearly injection of lenacapavir can maintain effective HIV deterrence degrees over 6 months.